UK & Europe
In-depth coverage of regulatory change and licensing frameworks across the UK & EU.
UK & Europe · page 5
- Medical Cannabis
France Extends Medical Cannabis Access Again as Full Access Bill Remains Stuck in Limbo
Thousands of French medical cannabis patients will continue to receive their treatment for the foreseeable future, as the highly anticipated full generalised framework edges towards reality.
- UK & Europe
The Battle for Germany’s Medical Cannabis Market: Who’s Fighting for What
Today, (Wednesday, January 14), a public hearing will bring together 22 hand-picked experts for a debate on the future country’s near-billion-euro medical cannabis industry.
- Medical Cannabis
Spanish Pharmacists Appeal Hospital-Only Cannabis Rule as Key Regulatory Deadline Passes Unmet
Spain represents one of the most exciting incoming additions to the European medical cannabis market this year, as one of the continent’s largest producers finally moves toward domestic patient access after years of hard-fought advocacy.
- Industry Trends
Inside the Medical Cannabis Police Guidance: Cancards, Driving, and What Patients Need to Know
Earlier this week, the first official guidance on medical cannabis for police officers in England and Wales was made public.
- Medical Cannabis
UK Police Finally Get Official Medical Cannabis Guidance More Than 7 Years After Legalisation
Over seven years after medical cannabis was legalised in the UK, the National Police Chiefs’ Council has approved the first official guidance for medical cannabis.
- International Regulation
Germany’s Medical Cannabis Bill Faces Critical Test as Experts Warn of ‘Unenforceable’ Framework
As Trump’s rescheduling executive order dominated the cannabis industry’s attention over the holiday period, Germany’s controversial medical cannabis bill quietly entered its most critical phase.
- Industry Trends
Germany’s Hidden Stigma Crisis: Why Pillar 2 is Still Sorely Needed
By: Dr. Sebastián Marincolo, Director of Strategic Content & Editorial, Weed.de Germany’s partial cannabis legalisation was originally designed to undercut the black market.
- Hemp Industry
UK Court Throws Out CBD Case Over Improper Testing, but Operators ‘More Vulnerable Than Ever’
A UK Crown Court has thrown out criminal charges against CBD hemp flower importers after ruling that police mishandled evidence and used improper testing methods, but only after a five-and-a-half-year ordeal that destroyed the defendants’ businesses and forced them to relocate abroad.
- Industry Trends
Bundesrat Backs Tighter Cannabis Prescribing Rules, Rejects Mail-Order Penalties
Germany’s Bundesrat voted on November 21 to support key restrictions on medical cannabis prescribing and distribution, while rejecting proposals to ban prescriptions being sent via mail, a mixed outcome that offers both relief and concern for an industry bracing for regulatory tightening.
- Clinical Research
EU ‘Intoxicating Hemp’ Review Highlights Major Knowledge Gaps Behind Blanket Bans
Last week, the US government voted to impose a blanket ban on all so-called ‘intoxicating hemp’ substances, ending what has been a contentious and long-running battle to regulate the recent emergence of THC substitutes.
- Clinical Research
Accredited Medical Cannabis Symposium Could ‘Benefit Thousands of Patients’, Says Expert
Accredited Medical Cannabis Symposium Could ‘Benefit Thousands of Patients’, Says Expert
- International Regulation
Drug War 2.0 Puts International Cannabis Reform at Risk
The United States is intensifying its controversial overseas ‘war on drugs’ even as a prolonged government shutdown paralyses domestic policy, a combination that threatens to reshape the outlook for cannabis reform and regulation This morning, news broke that the US military had carried out another series of airstrikes on alleged drug traffickers in the Eastern…
